A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

Clinical trial NCT03151811 · TERMINATED

Trial details

NCT number: NCT03151811
Sponsor: Oncopeptides AB
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2017-06-12
Primary completion: 2021-02-03
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.